Ceeto Capital Group’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-137,000
Closed -$541K 145
2020
Q4
$541K Buy
137,000
+57,000
+71% +$238K 0.27% 84
2020
Q3
$295K Buy
80,000
+44,000
+122% +$186K 0.16% 112
2020
Q2
$123K Sell
36,000
-166,000
-82% -$372K 0.08% 127
2020
Q1
$271K Buy
202,000
+118,000
+140% +$185K 0.22% 102
2019
Q4
$123K Sell
84,000
-94,000
-53% -$157K 0.08% 131
2019
Q3
$372K Sell
178,000
-6,000
-3% -$12.3K 0.27% 97
2019
Q2
$449K Buy
184,000
+9,000
+5% +$19.6K 0.33% 83
2019
Q1
$457K Buy
175,000
+66,000
+61% +$200K 0.34% 86
2018
Q4
$328K Buy
109,000
+18,000
+20% +$61K 0.27% 94
2018
Q3
$315K Buy
91,000
+2,000
+2% +$10.6K 0.22% 105
2018
Q2
$418K Buy
89,000
+40,000
+82% +$152K 0.31% 87
2018
Q1
$155K Sell
49,000
-75,000
-60% -$302K 0.12% 119
2017
Q4
$608K Sell
124,000
-1,000
-0.8% -$5.8K 0.43% 77
2017
Q3
$858K Buy
+125,000
New +$788K 0.64% 50

Other funds holding OPK

Ceeto Capital Group's OPK Position: Q1 2021 in Review

Ceeto Capital Group sold out of Opko Health (OPK) in Q1 2021, closing a stake of 137,000 shares — an estimated $541K sold.

Ceeto Capital Group first reported a position in OPK in Q3 2017 and held it in 14 quarters. The position peaked at $858K in Q3 2017. 239 funds tracked by Wall St. Rank hold OPK as of Q1 2021.

  • Ceeto Capital Group reported no remaining Opko Health position as of Q1 2021 after selling out during the quarter.
  • Ceeto Capital Group sold 137,000 Opko Health shares in Q1 2021, an estimated $541K.
  • Ceeto Capital Group first reported a position in Opko Health in Q3 2017 and held it in 14 quarters.
  • Ceeto Capital Group's Opko Health position peaked at $858K in Q3 2017.
  • 239 funds tracked by Wall St. Rank held Opko Health as of Q1 2021.

Based on Ceeto Capital Group's 13F filing for Q1 2021, filed 17 May 2021.